UCHIMA, Y., NISHII, T., ISEKI, Y., ISHII, M., HIRAMATSU, S., IWAUCHI, T., . . . TAKEUCHI, K. (2014). Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer. D.A. Spandidos.
Chicago Style CitationUCHIMA, YASUTAKE, et al. Retrospective Analysis of Capecitabine and Oxaliplatin (XELOX) Plus Bevacizumab As a First-line Treatment for Japanese Patients With Metastatic Colorectal Cancer. D.A. Spandidos, 2014.
Cita MLAUCHIMA, YASUTAKE, et al. Retrospective Analysis of Capecitabine and Oxaliplatin (XELOX) Plus Bevacizumab As a First-line Treatment for Japanese Patients With Metastatic Colorectal Cancer. D.A. Spandidos, 2014.
Atenció: Aquestes cites poden no estar 100% correctes.